Emmaus Life Sciences, Inc.
EMMA
$0.0165
$0.001510.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -72.86% | 26.28% | -1.08% | 63.06% | 64.87% |
| Total Depreciation and Amortization | -31.25% | -41.03% | -39.53% | -38.30% | -39.62% |
| Total Amortization of Deferred Charges | -72.43% | -42.78% | -19.30% | 24.87% | 41.49% |
| Total Other Non-Cash Items | -133.96% | -212.93% | -187.23% | -103.55% | 52.34% |
| Change in Net Operating Assets | 260.49% | 3,146.67% | 481.40% | -40.85% | -218.47% |
| Cash from Operations | -52.10% | -84.80% | 10.19% | 95.65% | 70.37% |
| Capital Expenditure | 29.41% | 36.84% | 31.58% | 50.00% | 34.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 704.34% | 270.73% | 207.06% | 114.33% | 82.42% |
| Cash from Investing | 678.70% | 267.74% | 205.38% | 113.92% | 81.90% |
| Total Debt Issued | -58.80% | -38.65% | -3.45% | -21.38% | -3.77% |
| Total Debt Repaid | 27.15% | -8.67% | -88.49% | -150.61% | -139.23% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -154.62% | -143.85% | -105.41% | -108.46% | -65.75% |
| Foreign Exchange rate Adjustments | -18.75% | -58.33% | 40.00% | -35.00% | 48.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -320.15% | -176.69% | -56.73% | -106.45% | 303.88% |